Innovation in medicine and device development, regulatory review, and use of clinical advances

JAMA - Journal of the American Medical Association

Volumn 316, Issue 16, 2016, Pages 1671-1672

  Rosenblatt, Michael ^a,b   Boutin, Marc M ^c   Nussbaum, Samuel R ^d,e  

^a Flagship VentureLabs   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c National Health Council   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e Wellpoint Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTERRORISM; CLINICAL DECISION MAKING; CLINICAL PRACTICE; DRUG DEVELOPMENT; DRUG SAFETY; HEALTH CARE; HEALTH CARE COST; HEALTH CARE DELIVERY; HUMAN; MEDICAL DEVICE; PRIORITY JOURNAL; SHORT SURVEY; CLINICAL TRIAL (TOPIC); DEVICES; DRUG APPROVAL; ECONOMICS; FOOD AND DRUG ADMINISTRATION; INTERNATIONAL COOPERATION; MACHINE LEARNING; PATIENT PARTICIPATION; PROCEDURES; UNITED STATES;

CLINICAL TRIALS AS TOPIC; DRUG APPROVAL; DRUG DISCOVERY; EQUIPMENT AND SUPPLIES; HUMANS; INTERNATIONALITY; MACHINE LEARNING; PATIENT PARTICIPATION; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84997124343     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.12486     Document Type: Short Survey

References (3)

1. Tufts Center for the Study of Drug Development. Outlook 2015. Boston, MA: Tufts University; 2015.
2. Ledford H. Translational research: 4 ways to fix the clinical trial. Nature. 2011;477(7366):526-528.
3. Hoos A, Anderson J, Boutin M, et al. Partnering with patients in the development and lifecycle of medicines: a call for action. Ther Innov Regul Sci. 2015;49(6):929-939.